CN109200050A - 一类生物碱在逆转肺癌顺铂耐药性方面的应用 - Google Patents
一类生物碱在逆转肺癌顺铂耐药性方面的应用 Download PDFInfo
- Publication number
- CN109200050A CN109200050A CN201811069730.1A CN201811069730A CN109200050A CN 109200050 A CN109200050 A CN 109200050A CN 201811069730 A CN201811069730 A CN 201811069730A CN 109200050 A CN109200050 A CN 109200050A
- Authority
- CN
- China
- Prior art keywords
- lung cancer
- resistant
- reversing
- cis
- alkaloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | IC50值(μg/ml) | 组别 | IC50值(μg/ml) |
H460组 | 14.21±1.25 | TB-3给药组 | 20.06±1.19 |
H460/DDP组 | 52.85±1.63 | TB-4给药组 | 48.72±1.55 |
TA-1给药组 | 21.07±1.47 | TC-1给药组 | 7.61±0.93 |
TA-2给药组 | 23.42±1.38 | TD-1给药组 | 7.33±0.88 |
TB-1给药组 | 18.95±1.10 | TE-1给药组 | 15.62±1.27 |
TB-2给药组 | 17.18±1.08 | TE-2给药组 | 9.24±0.96 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811069730.1A CN109200050B (zh) | 2018-09-13 | 2018-09-13 | 一类生物碱在逆转肺癌顺铂耐药性方面的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811069730.1A CN109200050B (zh) | 2018-09-13 | 2018-09-13 | 一类生物碱在逆转肺癌顺铂耐药性方面的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109200050A true CN109200050A (zh) | 2019-01-15 |
CN109200050B CN109200050B (zh) | 2020-11-20 |
Family
ID=64983712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811069730.1A Expired - Fee Related CN109200050B (zh) | 2018-09-13 | 2018-09-13 | 一类生物碱在逆转肺癌顺铂耐药性方面的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109200050B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112933110A (zh) * | 2021-02-03 | 2021-06-11 | 温州医科大学附属第六医院 | 一种用于肺癌患者对于化疗药物敏感性标记物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008475A (zh) * | 2010-09-09 | 2011-04-13 | 汕头大学医学院 | 喹诺里西啶生物碱在制备用于治疗肿瘤药物的应用 |
CN103509021A (zh) * | 2012-06-21 | 2014-01-15 | 上海药明康德新药开发有限公司 | 金雀花碱衍生物及其制备方法和抗癌作用研究 |
CN106913571A (zh) * | 2017-04-19 | 2017-07-04 | 山西大学 | 一种用于治疗肿瘤的药物及其应用 |
-
2018
- 2018-09-13 CN CN201811069730.1A patent/CN109200050B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008475A (zh) * | 2010-09-09 | 2011-04-13 | 汕头大学医学院 | 喹诺里西啶生物碱在制备用于治疗肿瘤药物的应用 |
CN103509021A (zh) * | 2012-06-21 | 2014-01-15 | 上海药明康德新药开发有限公司 | 金雀花碱衍生物及其制备方法和抗癌作用研究 |
CN106913571A (zh) * | 2017-04-19 | 2017-07-04 | 山西大学 | 一种用于治疗肿瘤的药物及其应用 |
Non-Patent Citations (2)
Title |
---|
LEI YU ET AL: "Cytisine induces endoplasmic reticulum stress caused by calcium overload in HepG2 cells", 《ONCOLOGY REPORTS》 * |
李泽慧等: "Multidrug resistance reversal activity of total alkaloid from Fritillaria thunb on cisplatin-resistant human lung adenocarcinoma A549/DDP cells", 《中国药理学与毒理学杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112933110A (zh) * | 2021-02-03 | 2021-06-11 | 温州医科大学附属第六医院 | 一种用于肺癌患者对于化疗药物敏感性标记物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109200050B (zh) | 2020-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Krausse et al. | In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, glycyrrhizin and its metabolites | |
Mady et al. | The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion | |
Vrzal et al. | Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum (II) and palladium (II) oxalato complexes with adenine derivatives as carrier ligands | |
CN101007050A (zh) | 含异补骨脂素的中药提取物及制备方法和用途 | |
Bao et al. | Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism | |
CN103877101A (zh) | 葫芦素在制备抗肿瘤药物中的应用 | |
Yang et al. | Anti-colorectal cancer effects of inonotus hispidus (Bull.: Fr.) p. karst. spore powder through regulation of gut microbiota-mediated JAK/STAT signaling | |
CN109200050A (zh) | 一类生物碱在逆转肺癌顺铂耐药性方面的应用 | |
Palupi et al. | Endophytic fungi inhabiting Physalis angulata L. plant: diversity, antioxidant, and antibacterial activities of their ethyl acetate extracts | |
CN109453164A (zh) | 一种抗肿瘤的联合用药物 | |
TWI797426B (zh) | 西奧羅尼用於小細胞肺癌的治療 | |
CN109172571A (zh) | 一种生物碱用于逆转肺癌顺铂耐药性的用途 | |
CN109045031A (zh) | 一种逆转肺癌顺铂耐药性的生物碱 | |
CN109172570A (zh) | 一种生物碱在制备防治肺癌患者顺铂耐药性的药物中的应用 | |
CN109172569A (zh) | 一种防治肺癌患者顺铂耐药性的生物碱化合物 | |
CN102688493A (zh) | 含有白藜芦醇及白藜芦醇类衍生物和Bc1-2抑制剂的药物组合物及其应用 | |
CN108125993A (zh) | 一种能逆转肿瘤多药耐药性的茯苓提取物的制备 | |
CN102688489B (zh) | 含有雷公藤甲素及雷公藤甲素类衍生物和Bcl-2抑制剂的药物组合物及其应用 | |
CN105213366B (zh) | 藤黄酮化合物的医药用途及其药物组合物 | |
CN101352448B (zh) | 短葶山麦冬皂苷c在制药中的应用 | |
CN102210668B (zh) | 斑蝥素及其衍生物在制备肿瘤化疗增敏药物中的应用 | |
CN107095876B (zh) | 二苯基联烯基氧膦化合物在制备治疗肺癌药物中的应用 | |
US20160361334A1 (en) | Application of baicalin in preparation of drug for treating ricin poisoning | |
CN1981749B (zh) | β-榄香烯用于抑制脑血管内皮细胞的用途 | |
CN109512825A (zh) | 一种铂类化合物和透明质酸钠的组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201021 Address after: Room 101, building 132, Baililai scientific innovation town, North Hunan Road, Liaocheng high tech Industrial Development Zone, Shandong Province 252000 Applicant after: Prosense (Shandong) Biomedical Technology Co.,Ltd. Address before: Room 201, 198 Hanhou Avenue, Qingjiangpu District, Huaian City, Jiangsu Province Applicant before: HUAI'AN YITAI BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201120 Termination date: 20210913 |
|
CF01 | Termination of patent right due to non-payment of annual fee |